MedPath

A study to evaluate the efficacy of Aragwadha Pushpa Lepa in the management of Vyanga with special reference to Melasma

Phase 2
Conditions
Health Condition 1: L811- Chloasma
Registration Number
CTRI/2022/07/043645
Lead Sponsor
Sri Sri College of Ayurvedic Science and Research Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Subjects fulfilling the diagnostic criteria of Vyanga with special reference to Melasma will be randomly selected, irrespective of their religion, occupation and socio-economic status

Exclusion Criteria

1) Female on oral contraceptive pills, pregnant women and lactating women

2) Who are on any hormonal therapy

3) Known hyperpigmentation since birth

4) Known inflammatory pigmentation

5) Known malignant melanoma

6) Any other condition interfering with the course of the treatment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improved uniformity in colour of facial skinTimepoint: 30 days
Secondary Outcome Measures
NameTimeMethod
Reduction in number of hyper pigmented lesions over facial skinTimepoint: 30 days
© Copyright 2025. All Rights Reserved by MedPath